About Prophecy Market Insights
Posted: Wed Feb 05, 2025 10:30 am
By product, the organic chemical is segment accounted for major revenue share in 2018, owing to it this organic chemicals increases efficiency regarding poorly soluble orally delivered molecules.
By functionality, fillers and diluents is segment accounted for major revenue share in 2018, due to increasing use of fillers and diluents in the development and production of solid oral drugs.
By formulation, parenteral formulations is segment accounted for major revenue share in 2018, attributed to parenteral formulations is major line treatment for infectious diseases, hepatitis, tuberculosis, cardiovascular diseases, diabetes, and cancer.
By region, The Europe pharmaceutical excipients china rcs data is expected to dominate in the global pharmaceutical excipients market and is further anticipated to maintain its dominance over the forecast period, owing topresence of European Medicines Agency’s scientific guidelines on excipients, which facilitates pharmaceutical entities to prepare marketing authorization applications for medicines for human consumption in the European countries. The North America pharmaceutical excipients market is expected to account for second-highest share in terms of revenue in the near future, followed by Asia Pacific in 2018.
Key Highlights:
On February 5, 2019, ABITEC Corporation launched “CAPMUL GDB EP/NF”. This is high-purity, highly-reproducible solid lipid exipient which offers good flow and uniform particle size distribution for use in multiple fomrulations, including tablets, hard gels, softgels, solid lipid nanoparticles, nano-structured lipids, granulations, multi-particulates, extrudates, congealing, and liquids.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “ Global Pharmaceutical Excipients Market, by Product (Organic Chemicals and Inorganic Chemicals), by Functionality (Fillers and Diluents, Binders, Disintegrants, Lubricants And Glidants, and Others (Coating Agents, Preservatives, Emulsifying Agents, and Flavoring Agents And Sweeteners)), by Formulation (Oral Formulations, Topical Formulations, Parenteral Formulations, and Others (Vaginal Inhaled, Ophthalmic, and Optic)), and by Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa)- forecast till 2029
To know the upcoming trends and insights prevalent in this market, click the link below.
By functionality, fillers and diluents is segment accounted for major revenue share in 2018, due to increasing use of fillers and diluents in the development and production of solid oral drugs.
By formulation, parenteral formulations is segment accounted for major revenue share in 2018, attributed to parenteral formulations is major line treatment for infectious diseases, hepatitis, tuberculosis, cardiovascular diseases, diabetes, and cancer.
By region, The Europe pharmaceutical excipients china rcs data is expected to dominate in the global pharmaceutical excipients market and is further anticipated to maintain its dominance over the forecast period, owing topresence of European Medicines Agency’s scientific guidelines on excipients, which facilitates pharmaceutical entities to prepare marketing authorization applications for medicines for human consumption in the European countries. The North America pharmaceutical excipients market is expected to account for second-highest share in terms of revenue in the near future, followed by Asia Pacific in 2018.
Key Highlights:
On February 5, 2019, ABITEC Corporation launched “CAPMUL GDB EP/NF”. This is high-purity, highly-reproducible solid lipid exipient which offers good flow and uniform particle size distribution for use in multiple fomrulations, including tablets, hard gels, softgels, solid lipid nanoparticles, nano-structured lipids, granulations, multi-particulates, extrudates, congealing, and liquids.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “ Global Pharmaceutical Excipients Market, by Product (Organic Chemicals and Inorganic Chemicals), by Functionality (Fillers and Diluents, Binders, Disintegrants, Lubricants And Glidants, and Others (Coating Agents, Preservatives, Emulsifying Agents, and Flavoring Agents And Sweeteners)), by Formulation (Oral Formulations, Topical Formulations, Parenteral Formulations, and Others (Vaginal Inhaled, Ophthalmic, and Optic)), and by Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa)- forecast till 2029
To know the upcoming trends and insights prevalent in this market, click the link below.